Seroatlas · Human Serome Atlas

PRG2

Bone marrow proteoglycan

Also known as: BMPG, MBP, PRG2_HUMAN, proMBP

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P13727
Gene
PRG2
Ensembl
ENSG00000186652
Chromosome
11
Canonical length
222 aa
Protein class
FDA approved drug targets, Plasma proteins, Predicted secreted proteins
Secretome location
Secreted in female reproductive system

OverviewNCBI Gene

The protein encoded by this gene is the predominant constituent of the crystalline core of the eosinophil granule. High levels of the proform of this protein are also present in placenta and pregnancy serum, where it exists as a complex with several other proteins including pregnancy-associated plasma protein A (PAPPA), angiotensinogen (AGT), and C3dg. This protein may be involved in antiparasitic defense mechanisms as a cytotoxin and helminthotoxin, and in immune hypersensitivity reactions. The encoded protein contains a peptide that displays potent antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria, and fungi. It is directly implicated in epithelial cell damage, exfoliation, and bronchospasm in allergic diseases. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2014]

Canonical amino-acid sequenceUniProt

222 residues, UniProt reviewed canonical sequence.

>P13727|PRG2
     1  MKLPLLLALL FGAVSALHLR SETSTFETPL GAKTLPEDEE TPEQEMEETP CRELEEEEEW
    61  GSGSEDASKK DGAVESISVP DMVDKNLTCP EEEDTVKVVG IPGCQTCRYL LVRSLQTFSQ
   121  AWFTCRRCYR GNLVSIHNFN INYRIQCSVS ALNQGQVWIG GRITGSGRCR RFQWVDGSRW
   181  NFAYWAAHQP WSRGGHCVAL CTRGGHWRRA HCLRRLPFIC SY

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against PRG2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.45
Highest tissue expression
2,458 nTPM

Expression across tissuesHPA

Tissue

  • placenta: 2,458 nTPM
  • bone marrow: 203 nTPM
  • thymus: 8.1 nTPM
  • pancreas: 3.6 nTPM
  • spleen: 3 nTPM
  • liver: 2.4 nTPM

Single-cell type

  • extravillous trophoblasts: 126 nCPM
  • monocyte progenitors: 3.2 nCPM
  • syncytiotrophoblasts: 2.8 nCPM
  • decidual stromal cells: 2.6 nCPM
  • migrating cytotrophoblasts: 2.1 nCPM
  • mast cells: 1.9 nCPM

Immune cell

  • basophil: 7.3 nTPM
  • eosinophil: 0.2 nTPM
  • total PBMC: 0.1 nTPM
  • classical monocyte: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM

Brain region

  • cerebral cortex: 0.3 nTPM
  • pons: 0.1 nTPM
  • amygdala: 0 nTPM
  • basal ganglia: 0 nTPM
  • cerebellum: 0 nTPM
  • choroid plexus: 0 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.27
gnomAD pLI
0
gnomAD missense Z
0.31
DepMap mean gene effect
-0.02
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of PRG2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads PRG2 as an antibody target. Whether an autoantibody or antibody against PRG2 could matter depends on whether native PRG2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

PRG2 is annotated as secreted, so native PRG2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label PRG2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/PRG2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...